Effects of switching from twice-daily to once-daily tacrolimus formulation on quality of life, anxiety, and transplant benefit perception after kidney transplantation
Articolo
Data di Pubblicazione:
2011
Citazione:
Calia, R., Lai, C., Aceto, P., Luciani, M., Romagnoli, J., Lai, S., Gargiulo, A., Citterio, F., Effects of switching from twice-daily to once-daily tacrolimus formulation on quality of life, anxiety, and transplant benefit perception after kidney transplantation, <>, 2011; 43 (4): 1020-1023. [doi:10.1016/j.transproceed.2011.03.048] [http://hdl.handle.net/10807/5482]
Abstract:
This study investigated whether switching from the twice-daily (Prograf; TAC) to the once-daily formulation of tacrolimus with extended release (Advagraf; XL) affected quality of life, anxiety, and transplant benefit perception after allogeneic kidney transplantation.
Tipologia CRIS:
Articolo in rivista, Nota a sentenza
Keywords:
Health Knowledge, Attitudes, Practice; Kidney Transplantation; Perception; Quality of Life; Adult; Aged; Analysis of Variance; Anxiety; Delayed-Action Preparations; Drug Administration Schedule; Drug Monitoring; Female; Graft Rejection; Humans; Immunosuppressive Agents; Italy; Male; Middle Aged; Psychiatric Status Rating Scales; Questionnaires; Tacrolimus; Time Factors; Treatment Outcome; Truth Disclosure
Elenco autori:
Calia, Rosaria; Lai, Carlo; Aceto, Paola; Luciani, Massimiliano; Romagnoli, Jacopo; Lai, S; Gargiulo, Antonio; Citterio, Franco
Link alla scheda completa:
Pubblicato in: